Virginia Retirement Systems Et Al Tg Therapeutics, Inc. Transaction History

Virginia Retirement Systems Et Al

$15 Billion
Q3 2025

A detailed history of Virginia Retirement Systems Et Al transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 46,731 shares of TGTX stock, worth $1.45 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

46,731

Previous 49,731 6.03%

Holding current value

$1.45 Million

Previous $1.79 Million 5.65%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	SELL	$26.39 - $39.19 $79,170 - $117,570	-3,000 Reduced 6.03%	46,731 $1.69 Million
Q1 2025 Jul 16, 2025	BUY	$27.67 - $42.99 $410,373 - $637,584	14,831 Added 42.5%	49,731 $1.96 Million
Q3 2023 Jan 02, 2024	SELL	$8.36 - $26.5 $136,268 - $431,950	-16,300 Reduced 31.84%	34,900 $291,000
Q2 2023 Aug 22, 2023	SELL	$15.48 - $35.0 $450,468 - $1.02 Million	-29,100 Reduced 36.24%	51,200 $1.27 Million
Q1 2023 Jul 11, 2023	BUY	$10.23 - $19.34 $224,037 - $423,546	21,900 Added 37.5%	80,300 $1.21 Million

Q4 2022 May 17, 2023	BUY	$5.01 - $11.83 $26,052 - $61,516	5,200 Added 9.77%	58,400 $691 Million
Q3 2022 May 16, 2023	BUY	$4.57 - $8.4 $175,031 - $321,720	38,300 Added 257.05%	53,200 $315 Million
Q1 2022 Apr 21, 2022	SELL	$7.81 - $20.45 $21,868 - $57,260	-2,800 Reduced 15.82%	14,900 $142,000
Q4 2021 Feb 03, 2022	BUY	$15.2 - $35.51 $269,040 - $628,527	17,700 New	17,700 $336,000
Q2 2021 Aug 13, 2021	SELL	$32.5 - $48.96 $302,250 - $455,328	-9,300 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$41.61 - $54.3 $145,635 - $190,050	-3,500 Reduced 27.34%	9,300 $448,000
Q4 2020 Feb 16, 2021	SELL	$25.27 - $54.9 $401,793 - $872,910	-15,900 Reduced 55.4%	12,800 $666,000
Q3 2020 Nov 12, 2020	SELL	$18.49 - $27.24 $933,744 - $1.38 Million	-50,500 Reduced 63.76%	28,700 $768,000
Q2 2020 Aug 12, 2020	SELL	$8.9 - $21.84 $329,300 - $808,080	-37,000 Reduced 31.84%	79,200 $1.54 Million
Q1 2020 May 12, 2020	BUY	$7.14 - $15.99 $184,212 - $412,542	25,800 Added 28.54%	116,200 $1.14 Million
Q4 2019 Jan 27, 2020	BUY	$5.1 - $11.2 $270,300 - $593,600	53,000 Added 141.71%	90,400 $1 Million
Q3 2019 Oct 22, 2019	BUY	$5.38 - $8.99 $201,212 - $336,226	37,400 New	37,400 $210,000

Others Institutions Holding TGTX

# of Institutions

397

Shares Held

92.6M

Call Options Held

1.77M

Put Options Held

1.9M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.5B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Account

Virginia Retirement Systems Et Al Tg Therapeutics, Inc. Transaction History